Healthcare provider profile · identity verified

Michael Rolfsen, MD

Internal Medicine · BATON ROUGE, LA · NPI 1770504474

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	1088	297
Atorvastatin Calcium	Atorvastatin Calcium	887	241
Amlodipine Besylate	Amlodipine Besylate	813	210
Hydrochlorothiazide	Hydrochlorothiazide	692	181
Levothyroxine Sodium	Levothyroxine Sodium	604	153
Rosuvastatin Calcium	Rosuvastatin Calcium	592	160
Lisinopril	Lisinopril	452	115
Metoprolol Succinate	Metoprolol Succinate	443	125
Trazodone Hcl	Trazodone Hcl	332	81
Pantoprazole Sodium	Pantoprazole Sodium	310	101
Omeprazole	Omeprazole	287	83
Metformin Hcl Er	Metformin Hcl	285	85
Gabapentin	Gabapentin	276	85
Escitalopram Oxalate	Escitalopram Oxalate	250	69
Eliquis	Apixaban	226	48
Ozempic	Semaglutide	220	40
Spironolactone	Spironolactone	210	59
Metformin Hcl	Metformin Hcl	201	52
Duloxetine Hcl	Duloxetine Hcl	192	54
Tamsulosin Hcl	Tamsulosin Hcl	189	57
Glimepiride	Glimepiride	188	44
Pravastatin Sodium	Pravastatin Sodium	188	51
Meloxicam	Meloxicam	186	61
Sertraline Hcl	Sertraline Hcl	183	41
Simvastatin	Simvastatin	176	45
Furosemide	Furosemide	160	54
Mirtazapine	Mirtazapine	143	40
Montelukast Sodium	Montelukast Sodium	140	40
Alendronate Sodium	Alendronate Sodium	130	36
Citalopram Hbr	Citalopram Hydrobromide	124	34
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	119	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	113	26
Ezetimibe	Ezetimibe	110	30
Allopurinol	Allopurinol	105	32
Jardiance	Empagliflozin	103	22
Carvedilol	Carvedilol	99	27
Celecoxib	Celecoxib	97	21
Albuterol Sulfate Hfa	Albuterol Sulfate	96	36
Alprazolam	Alprazolam	93	35
Metoprolol Tartrate	Metoprolol Tartrate	92	24
Fluoxetine Hcl	Fluoxetine Hcl	91	26
Lorazepam	Lorazepam	89	20
Buspirone Hcl	Buspirone Hcl	88	21
Clonazepam	Clonazepam	88	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	23
Bupropion Xl	Bupropion Hcl	82	20
Tramadol Hcl	Tramadol Hcl	81	32
Hydralazine Hcl	Hydralazine Hcl	75	17
Oxybutynin Chloride Er	Oxybutynin Chloride	75	24
Memantine Hcl	Memantine Hcl	74	20
Clopidogrel	Clopidogrel Bisulfate	73	23
Zolpidem Tartrate	Zolpidem Tartrate	73	26
Fluticasone Propionate	Fluticasone Propionate	68	24
Mounjaro	Tirzepatide	68	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	61	40
Synthroid	Levothyroxine Sodium	61	18
Benazepril Hcl	Benazepril Hcl	59	14
Oxybutynin Chloride	Oxybutynin Chloride	58	13
Potassium Chloride	Potassium Chloride	57	23
Tizanidine Hcl	Tizanidine Hcl	51	27
Estradiol	Estradiol	50	16
Verapamil Er	Verapamil Hcl	50	14
Atenolol	Atenolol	49	13
Dilt-Xr	Diltiazem Hcl	48	11
Prednisone	Prednisone	47	28
Donepezil Hcl	Donepezil Hcl	45	16
Esomeprazole Magnesium	Esomeprazole Magnesium	44	12
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Finasteride	Finasteride	40	13
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Valsartan	Valsartan	37	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Myrbetriq	Mirabegron	32	11
Valacyclovir	Valacyclovir Hcl	32	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	16
Propranolol Hcl	Propranolol Hcl	31	suppressed
Cephalexin	Cephalexin	30	21
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	11
Indapamide	Indapamide	29	suppressed
Xarelto	Rivaroxaban	29	12
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Glipizide	Glipizide	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Azithromycin	Azithromycin	27	27
Terazosin Hcl	Terazosin Hcl	27	suppressed
Temazepam	Temazepam	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	24	22
Novolog Flexpen	Insulin Aspart	24	suppressed
Dutasteride	Dutasteride	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Nystatin	Nystatin	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	11
Hydrocortisone	Hydrocortisone	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Diazepam	Diazepam	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	19	suppressed
Ondansetron Odt	Ondansetron	19	17
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Famotidine	Famotidine	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Verapamil Sr	Verapamil Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Topiramate	Topiramate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Complera	Emtricita/Rilpivirine/Tenof Df	12	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Linzess	Linaclotide	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Modafinil	Modafinil	12	suppressed
Cevimeline Hcl	Cevimeline Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error